Resumo

LOPEZ DE CASTRO, Francisco et al. Quality of life of people with insomnia in the Toledo health area. Rev Clin Med Fam [online]. 2011, vol.4, n.2, pp.92-99. ISSN 2386-8201.

Objective: Clinical assessment and quality of life of the insomniac patient. Design: cross-sectional study. Setting: Primary Health Care. Toledo (Spain). Participants: Patients diagnosed with insomnia before January 2009. Measurements: Medical history review: record of diagnostic and therapeutic activities. Telephone interview: sleep history and EQ-5D questionnaire Results: N = 94. Average age 60.3 ± 14.3 years, 79.8% are women. 73.4% (95%CI 62.0-80.0%) had less than 90% sleep efficiency and 69.1% said they sleep badly. Impact: 76.8% get up feeling tired; in 70.6% insomnia interferes with their activities, in 63.2% it causes distractions and in 39.7% daytime sleepiness. 58.1% have conciliation insomnia, 25.8% have maintenance insomnia, and 8.6% early awakening. 27.8% of patients received advice on sleep hygiene. The most commonly prescribed drugs were lorazepam (47.2%), lormetazepam (23.6%) and zolpidem (19.1%). Median duration of treatment was 32 weeks (RI 58). Currently 24.7% are not taking any treatment, 21.7% of whom said they sleep well. 17.2% of those who were treated and 26.1% of those who were not considered they were in good or very good health. Older patients (r= -0.33; p = 0.001), those who said they sleep badly (55.8 vs 53.2; t = 0, 52; p > 0.05), those with early awakening (F = 3.51; p = 0.01) and those on pharmacotherapy (51.5 vs 61.5; t = 1.93 p = 0.06) had the worst scores in the EQ5D. Conclusions: Most patients with insomnia continue to sleep badly and have poor sleep efficiency, even with pharmacological treatment. The main impact is tiredness, which interferes with their normal activities. Insomnia has a negative effect on the quality of life.

Palavras-chave : Insomnia; Quality of Life; Hypnotics.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )